Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102174020B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 5-(4-methyl-1H-imidazol-1-yl)-3-trifluoromethyl-aniline via patent CN102174020B. Delivers superior purity, safety, and cost efficiency for kinase inhibitor supply chains.